Startup profile · funding coverage
Counsel Health
Physician-supervised async AI medical advice and virtual care messaging platform.
Stage
series a
Status
private
Coverage
full
Why Counsel Health is interesting
Hybrid AI-clinician model for messaging-based care — Pear and Floodgate in seed; Kleiner joined a16z in the $25M Series A.
Key facts
- Series A (2025): $25M co-led by a16z and GV; Kleiner Perkins among participants (BusinessWire)
- Seed (2024): $11M led by a16z Bio+Health; Asymmetric, Floodgate, Pear VC participated (PR Newswire)
Investors in our directory
Funds linked from Counsel Health's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech AI & Machine Learning
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
Related funding articles
Venture Capital Tracker pieces that cover Counsel Health's financing or category context.
FAQs about Counsel Health
Funding context and why this company shows up in venture coverage.
Counsel Health provides async medical advice through a messaging platform — AI drafts responses that licensed physicians review and approve, giving patients on-demand health guidance without scheduling appointments.
Andreessen Horowitz (see /fund/andreessen-horowitz) led the $11M seed and co-led the $25M Series A. Pear VC (see /fund/pear-vc), Floodgate (see /fund/floodgate), and Kleiner Perkins (see /fund/kleiner-perkins) also participated.
Series A ($25M, 2025) following an $11M seed in 2024. The company remains private.
Primary care access is strained. Counsel tests whether AI-assisted async messaging — with physician oversight — can extend care capacity without the liability of fully autonomous medical AI.
No — Counsel Health remains a private company.
Last updated: 2026-07-24